RK Capital Management (Colorado)’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,160
Closed -$5.65M 39
2024
Q2
$5.65M Buy
+17,160
New +$6.06M 1.51% 29
2022
Q3
Sell
-45,700
Closed -$13.8M 56
2022
Q2
$13.8M Buy
45,700
+6,560
+17% +$2.13M 3.25% 6
2022
Q1
$16.1M Buy
39,140
+21,930
+127% +$8.59M 3.15% 4
2021
Q4
$8.07M Buy
17,210
+7,565
+78% +$3.26M 1.47% 34
2021
Q3
$4.09M Sell
9,645
-5,355
-36% -$2.26M 0.78% 55
2021
Q2
$5.39M Sell
15,000
-10,535
-41% -$3.48M 1.01% 54
2021
Q1
$7.2M Buy
25,535
+8,835
+53% +$2.53M 1.43% 37
2020
Q4
$4.73M Buy
16,700
+9,700
+139% +$2.72M 1.05% 48
2020
Q3
$1.92M Sell
7,000
-3,900
-36% -$1.03M 0.55% 59
2020
Q2
$2.48M Buy
10,900
+1,600
+17% +$314K 0.72% 55
2020
Q1
$1.42M Buy
+9,300
New +$1.43M 0.64% 49
2018
Q4
Sell
-20,171
Closed -$2.49M 55
2018
Q3
$2.49M Sell
20,171
-42,229
-68% -$4.74M 0.56% 49
2018
Q2
$6.2M Sell
62,400
-28,600
-31% -$2.63M 1.37% 37
2018
Q1
$8.03M Buy
+91,000
New +$8.51M 1.74% 28
2017
Q4
Sell
-38,000
Closed -$3.66M 55
2017
Q3
$3.66M Buy
+38,000
New +$3.44M 0.85% 45

Other funds holding WST

RK Capital Management (Colorado)'s WST Position: Q3 2024 in Review

RK Capital Management (Colorado) sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 17,160 shares — an estimated $5.65M sold.

RK Capital Management (Colorado) first reported a position in WST in Q3 2017 and held it in 15 quarters. The position peaked at $16.1M in Q1 2022. 729 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • RK Capital Management (Colorado) reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • RK Capital Management (Colorado) sold 17,160 West Pharmaceutical shares in Q3 2024, an estimated $5.65M.
  • RK Capital Management (Colorado) first reported a position in West Pharmaceutical in Q3 2017 and held it in 15 quarters.
  • RK Capital Management (Colorado)'s West Pharmaceutical position peaked at $16.1M in Q1 2022.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on RK Capital Management (Colorado)'s 13F filing for Q3 2024, filed 13 Nov 2024.